Dr. Boris Bagdasarian

Oncology | Hematology
1505 Wilson Terrace, Suite 200, 
Glendale, CA 
Accepting New Patients
Offers Telehealth
1505 Wilson Terrace, Suite 200, 
Glendale, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Boris Bagdasarian is a Hematologist and an Oncologist in Glendale, California. Dr. Bagdasarian is rated as an Experienced provider by MediFind in the treatment of Drug-Induced Thrombocytopenia. His top areas of expertise are Agranulocytosis, Chronic Familial Neutropenia, Langerhans Cell Histiocytosis, and Thrombocytopenia. Dr. Bagdasarian is currently accepting new patients.

His clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology
Licenses
Internal Medicine in CA
Hospital Affiliations
Keck Hospital Of USC
USC Verdugo Hills Hospital
Glendale Adventist Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

1505 Wilson Terrace, Suite 200, Glendale, CA 91206

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter, Randomized, Open-label Phase 2 Study Evaluating the Safety and Efficacy of Three Different Regimens of Oral Panobinostat in Combination With Subcutaneous Bortezomib and Oral Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma Who Have Been Previously Exposed to Immunomodulatory Agents
A Multicenter, Randomized, Open-label Phase 2 Study Evaluating the Safety and Efficacy of Three Different Regimens of Oral Panobinostat in Combination With Subcutaneous Bortezomib and Oral Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma Who Have Been Previously Exposed to Immunomodulatory Agents
Enrollment Status: Completed
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drugs: Panobinostat Capsules, Bortezomib Injection, Dexamethasone Tablets
Study Phase: Phase 2
A Phase II, Multicenter Study of Oral MET Inhibitor INC280 in Adult Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)
A Phase II, Multicenter Study of Oral MET Inhibitor INC280 in Adult Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)
Enrollment Status: Completed
Publish Date: March 20, 2024
Intervention Type: Drug
Study Drug: INC280
Study Phase: Phase 2
A Phase Ib/II, Open-label, Multicenter Trial With Oral cMET Inhibitor INC280 Alone and in Combination With Erlotinib Versus Platinum With Pemetrexed in Adult Patients With EGFR Mutated, cMET-amplified, Locally Advanced/Metastatic Non-small Cell Lung Cancer (NSCLC) With Acquired Resistance to Prior EGFR Tyrosine Kinase Inhibitor (EGFR TKI)
A Phase Ib/II, Open-label, Multicenter Trial With Oral cMET Inhibitor INC280 Alone and in Combination With Erlotinib Versus Platinum With Pemetrexed in Adult Patients With EGFR Mutated, cMET-amplified, Locally Advanced/Metastatic Non-small Cell Lung Cancer (NSCLC) With Acquired Resistance to Prior EGFR Tyrosine Kinase Inhibitor (EGFR TKI)
Enrollment Status: Terminated
Publish Date: February 24, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials
Similar Doctors
Distinguished in Drug-Induced Thrombocytopenia
Dr. Jayaram S. Bharadwaj
Hematology Oncology | Oncology
Distinguished in Drug-Induced Thrombocytopenia
Dr. Jayaram S. Bharadwaj
Hematology Oncology | Oncology
1801 W Romneya Dr, Suite 203, 
Anaheim, CA 
 (26.3 miles away)
714-999-9146
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jayaram Bharadwaj is a Hematologist Oncology specialist and an Oncologist in Anaheim, California. Dr. Bharadwaj is rated as a Distinguished provider by MediFind in the treatment of Drug-Induced Thrombocytopenia. His top areas of expertise are Drug-Induced Thrombocytopenia, Thrombocytopenia, Agranulocytosis, and Anemia.

Nubar P. Boghossian
Advanced in Drug-Induced Thrombocytopenia
Dr. Nubar P. Boghossian
Oncology | Hematology
Advanced in Drug-Induced Thrombocytopenia
Dr. Nubar P. Boghossian
Oncology | Hematology

Los Angeles Cancer Network

222 W Eulalia St, Ste 100C, 
Glendale, CA 
 (2.2 miles away)
818-553-8160
Languages Spoken:
English, Arabic, Armenian, French, Spanish, Swedish
See accepted insurances
Accepting New Patients
Offers Telehealth

The mission of The Los Angeles Cancer Network is to provide compassionate individualized treatment using the most recent proven advances in cancer care as well as education and support to our patients and their families. It is also our mission to participate in important clinical research, early detection and innovative treatment. We are proud to be at the forefront of cancer research with our associates at Southwest Oncology Group and Kenmar Research Institute. I am privileged to be able to take care of our cancer patients. Dr. Boghossian is rated as a Distinguished provider by MediFind in the treatment of Drug-Induced Thrombocytopenia. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Agranulocytosis, and Chronic Familial Neutropenia.

Distinguished in Drug-Induced Thrombocytopenia
Dr. Anas Raowas
Hematology Oncology | Hematology | Oncology
Distinguished in Drug-Induced Thrombocytopenia
Dr. Anas Raowas
Hematology Oncology | Hematology | Oncology

Los Angeles Hematology-Oncology Medical Group

4500 Brockton Ave, Suite 107, 
Riverside, CA 
 (50.0 miles away)
951-276-2760
Languages Spoken:
English
See accepted insurances

Anas Raowas is a Hematologist Oncology specialist and a Hematologist in Riverside, California. Dr. Raowas is rated as an Advanced provider by MediFind in the treatment of Drug-Induced Thrombocytopenia. His top areas of expertise are Drug-Induced Thrombocytopenia, Thrombocytopenia, Anemia, and Essential Thrombocythemia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bagdasarian's expertise for a condition
ConditionClose
    View All 24 Distinguished Conditions
    View All 92 Advanced Conditions
    View All 79 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile